Hemorrhagic retinopathy occurred more frequently in reports listing versus those not listing GLP-1RA, but this difference did not reach statistical significance and a quite similar and more common AE (retinal hemorrhage) occurred much less frequently and with high statistical significance in reports with GLP-1RA.
← all excerpts
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System.
1
—
—